Covid-19

Thursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3 COVID-19 pre-exposure prophylaxis (prevention) trial. The study showed AstraZeneca's sipavibart (formerly AZD3152), an investigational long-acting antibody (LAAB),...

Rep. Marjorie Taylor Greene (R-Ga.) praised the courage of Slovakia’s Prime Minister, Robert Fico, following an assassination attempt, in relation to his stance on the World Health Organization and COVID-19 vaccinations. What Happened: On Wednesday, Greene took to X, formerly Twitter, to...

AstraZeneca (NASDAQ:AZN) has declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” What Happened: The company began the withdrawal process on Tuesday, attributing the decision to the proliferation and availability of multiple variants...

Tesla and SpaceX CEO Elon Musk has seemingly supported Rep. Jim Jordan (R-Ohio) in his criticism of the Joe Biden administration’s alleged suppression of the lab leak theory. What Happened: On Wednesday, the tech billionaire reacted to Jordan’s thread on X, formerly Twitter. In his...

Pfizer Inc (NYSE:PFE) stock has declined significantly due to decreased revenue from its COVID-19 products. The stock is down 34.61% over the past year, and 10.94% year-to-date. While Pfizer’s dividend appears to be inexpensive, investors are noting significant risks facing the company ahead...

CNBC’s “Mad Money” host Jim Cramer urged investors to reflect on the stock market’s performance during the pandemic to gain a deeper understanding of the current economic climate. What Happened: On Thursday, Cramer suggested investors should revisit the pandemic era to...

A Delaware District Court sided with Arbutus Biopharma Corporation (NASDAQ:ABUS) and Genevant Sciences in their ongoing patent infringement case against Moderna Inc (NASDAQ:MRNA) COVID-19 vaccine. The companies jointly submitted a claim construction brief to the Delaware district court, seeking...

Shares in Arbutus Biopharma (NASDAQ:ABUS) soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna Inc (NASDAQ:MRNA) in court. What Happened: Arbutus first filed its patent infringement complaint against Moderna, over the messenger-RNA...

On Tuesday, Cathie Wood’s Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccine maker. This move comes amidst a series of upcoming catalysts for the biotech firm. The MRNA Trade Ark Invest, through its flagship Ark Innovation ETF...

In a recent revelation, the marriage rate in the United States has bounced back to the levels seen before the COVID-19 pandemic. This comes after a year of delayed engagements due to the pandemic. What Happened: The National Center for Health Statistics, a division of the Centers for Disease...

For the last few years, the Center for Disease Control and Prevention has recommended that individuals with COVID-19 isolate for at least five days before returning to school or work. Now, the CDC has new guidelines. What Happened: The agency announced on Friday that people infected with COVID-19...

The Centers for Disease Control and Prevention (CDC) has recommended a second annual COVID-19 vaccine for individuals aged 65 and above. This decision comes in the wake of a significant increase in COVID-19 hospitalizations among older Americans. What Happened: The CDC’s Advisory Committee...

Moderna Inc (NASDAQ:MRNA) will be reporting its fourth-quarter earnings on Feb. 22. Wall Street expects a negative 99 cents in EPS and $2.53 billion in revenues as the company reports before market hours. Moderna is renowned for its development of mRNA-based vaccines, including the COVID-19 vaccine...

The bond market is bracing for a potential policy shift by the Federal Reserve, with expectations of a move away from interest rate hikes to multiple rate cuts this year. What Happened: Bond investors are gearing up for a possible change in the Federal Reserve’s interest rate policy...

A Canadian federal court determined this week that Prime Minister Justin Trudeau violated the nation's Charter of Rights and Freedoms. What Happened: Trudeau's use of the Emergencies Act in 2022 was aimed at stopping truck drivers' protests against COVID-19 mandates and their Bitcoin (...